Globeflex Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Globeflex Capital’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,866	Closed	-$465K	–	541
2022 Q3	$465K	Sell	9,866 -2,461	-20%	-$159K	0.08%	257
2022 Q2	$884K	Sell	12,327 -1,903	-13%	-$139K	0.22%	137
2022 Q1	$1.15M	Hold	14,230	–	–	0.23%	122
2021 Q4	$1.46M	Hold	14,230	–	–	0.3%	97
2021 Q3	$1.25M	Sell	14,230 -19,407	-58%	-$1.76M	0.27%	116
2021 Q2	$3.01M	Buy	33,637 +7,980	+31%	+$674K	0.54%	42
2021 Q1	$1.95M	Hold	25,657	–	–	0.35%	78
2020 Q4	$1.75M	Buy	25,657 +419	+2%	+$26.1K	0.37%	68
2020 Q3	$1.34M	Sell	25,238 -2,831	-10%	-$169K	0.36%	79
2020 Q2	$1.64M	Sell	28,069 -5,367	-16%	-$288K	0.41%	51
2020 Q1	$1.32M	Sell	33,436 -5,752	-15%	-$336K	0.41%	53
2019 Q4	$2.33M	Sell	39,188 -729	-2%	-$39.2K	0.44%	43
2019 Q3	$2.12M	Hold	39,917	–	–	0.46%	42
2019 Q2	$2.04M	Buy	39,917 +2,657	+7%	+$124K	0.42%	47
2019 Q1	$1.93M	Buy	37,260 +19,636	+111%	+$952K	0.41%	53
2018 Q4	$694K	Hold	17,624	–	–	0.17%	217
2018 Q3	$909K	Buy	17,624 +12,414	+238%	+$608K	0.18%	200
2018 Q2	$244K	Hold	5,210	–	–	0.05%	369
2018 Q1	$185K	Buy	5,210 +400	+8%	+$15.7K	0.04%	388
2017 Q4	$210K	Sell	4,810 -23,486	-83%	-$1.1M	0.06%	305
2017 Q3	$1.48M	Sell	28,296 -2,250	-7%	-$125K	0.42%	61
2017 Q2	$1.79M	Hold	30,546	–	–	0.44%	51
2017 Q1	$1.4M	Buy	30,546 +25,746	+536%	+$1.28M	0.33%	98
2016 Q4	$252K	Sell	4,800 -500	-9%	-$24.2K	0.06%	331
2016 Q3	$236K	Buy	+5,300	New	+$230K	0.06%	327
2016 Q2	–	Sell	-19,600	Closed	-$808K	–	539
2016 Q1	$808K	Hold	19,600	–	–	0.22%	164
2015 Q4	$951K	Buy	19,600 +300	+2%	+$13.3K	0.25%	159
2015 Q3	$772K	Buy	+19,300	New	+$843K	0.17%	225
2015 Q2	–	Sell	-19	Closed	-$1K	–	605
2015 Q1	$1K	Buy	+19	New	+$525	﹤0.01%	480

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Globeflex Capital's SYNH Position: Q4 2022 in Review

Globeflex Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 9,866 shares — an estimated $465K sold.

Globeflex Capital first reported a position in SYNH in Q1 2015 and held it in 29 quarters. The position peaked at $3.01M in Q2 2021. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Globeflex Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Globeflex Capital sold 9,866 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $465K.
Globeflex Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 29 quarters.
Globeflex Capital's Syneos Health, Inc. Class A Common Stock position peaked at $3.01M in Q2 2021.
307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Globeflex Capital's 13F filing for Q4 2022, filed 10 Feb 2023.